ReviewMedicina (Kaunas, Lithuania)2026

Metabolic Dysfunction-Associated Steatotic Liver Disease and Incretin Receptor Agonists: A Metabolic Approach to Halting Liver Disease Progression.

Ludovico Abenavoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.